Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
1994-6-9
|
| pubmed:abstractText |
A putative model of bradykinin bound to the rat B2 receptor was generated using a combination of homology modeling (from the known transmembrane structure of bacteriorhodopsin), energy minimization, molecular dynamics, and a two-stage conformational search as a docking simulation. Overall, the proposed bound ligand adopts a twisted "S" shape, wherein a C-terminal beta-turn is buried in the receptor just below the extracellular boundary of the cell membrane and the N-terminus is interacting with negatively charged residues in extracellular loop 3 of the receptor (most notably Asp268 and Asp286). Mutagenesis experiments describing mutations which result in both a loss of bradykinin affinity as well as those which have no effect on bradykinin affinity are in good agreement with the proposed structure. In short, the mutagenesis results and the computational simulations each point to the same region of the receptor as likely to bind bradykinin. A double mutation, predicted as being likely to have a dramatic effect on bradykinin binding affinity, was confirmed experimentally, adding some validation to the proposed complex. Moreover, a new pseudopeptide bradykinin receptor antagonist (D-Arg0-Arg1-[12-aminododecanoyl]2- Ser3-D-Tic4-Oic5-Arg6) was designed on the basis of the model, and found to have good receptor affinity. Speculation regarding other possible sites for mutagenesis are also described.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alanine,
http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin,
http://linkedlifedata.com/resource/pubmed/chemical/Glutamates,
http://linkedlifedata.com/resource/pubmed/chemical/Glutamic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Bradykinin
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0022-2623
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
29
|
| pubmed:volume |
37
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1347-54
|
| pubmed:dateRevised |
2003-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:7909848-Alanine,
pubmed-meshheading:7909848-Amino Acid Sequence,
pubmed-meshheading:7909848-Animals,
pubmed-meshheading:7909848-Bradykinin,
pubmed-meshheading:7909848-Cell Membrane,
pubmed-meshheading:7909848-Computer Simulation,
pubmed-meshheading:7909848-Drug Design,
pubmed-meshheading:7909848-Electrochemistry,
pubmed-meshheading:7909848-Glutamates,
pubmed-meshheading:7909848-Glutamic Acid,
pubmed-meshheading:7909848-Models, Molecular,
pubmed-meshheading:7909848-Molecular Sequence Data,
pubmed-meshheading:7909848-Mutagenesis, Site-Directed,
pubmed-meshheading:7909848-Point Mutation,
pubmed-meshheading:7909848-Protein Conformation,
pubmed-meshheading:7909848-Protein Structure, Secondary,
pubmed-meshheading:7909848-Rats,
pubmed-meshheading:7909848-Receptors, Bradykinin,
pubmed-meshheading:7909848-Thermodynamics
|
| pubmed:year |
1994
|
| pubmed:articleTitle |
A proposed model of bradykinin bound to the rat B2 receptor and its utility for drug design.
|
| pubmed:affiliation |
Scios Nova Inc., Baltimore, Maryland 21224.
|
| pubmed:publicationType |
Journal Article
|